Mannatech launches scientific Web site
COPPELL, Texas Mannatech on Thursday announced the launch of its scientific Web site, www.MannatechScience.org, which outlines the clinical support behind its proprietary product lines of dietary supplements.
“The hallmark of the Web site is Mannatech’s research,” stated Robert Sinnott, chief science officer and SVP, Mannatech. “Working in collaboration with scientists around the world, Mannatech has published and presented 16 studies, reviewing the scientific findings of its products and product ingredients, including Ambrotose products, BounceBack capsules, EMPACT energy and endurance formula and OsoLean powder.”
The company’s new Web site provides research information, including Mannatech’s published pre-clinical and clinical studies, and basic identity and safety information around the ingredients in Mannatech products.
FDA approves new packaging of Children’s Zyrtec Allergy
ROCKVILLE, Md. The Food and Drug Administration on Friday approved new packaging for McNeil Consumer Healthcare’s Children’s Zyrtec Allergy syrup, grape sugar-free, dye-free flavor, in a letter addressed to the supplier.
The new packaging will include a prefilled dosing spoon that will deliver a single dose, or 5 mg, of Zyrtec (cetirizine).
LifeScan, Apple demonstrate prototype diabetes management software
MILPITAS, Calif. Johnson & Johnson’s LifeScan on Tuesday demonstrated a prototype diabetes management software application, integrating the company’s OneTouch blood glucose meters with the Apple iPhone and iPod touch products. LifeScan was one of a handful of companies invited by Apple to develop and preview innovative new applications at Apple’s iPhone OS 3.0 software event, the company stated.
Using a modified OneTouch Meter, the prototype application demonstrated transmission of a blood glucose test result to the Apple iPhone. Once on the iPhone, test results were available for integration with other information in a series of user-friendly graphics, including the user’s level of glucose control over time relative to targets established with his or her healthcare professional.
The application also will include a customizable food database to help users determine the amount of carbohydrates consumed during meals. Future applications also may include the capability for users to calculate a bolus insulin dose based on the last glucose result and the number of carbohydrates that will be consumed.
The new OneTouch/iPhone application is in the early stages of development, the company noted.